Scribd Logo
Upload

Welcome to Scribd!

  • 20 views

    Gout Supplementary Data Appendix A

    Uploaded by

    acoolz90
    Specific relationships were disclosed between researchers and URL Pharma (Colchicine), Takeda (Febuxostat), Amgen/Biovitrum/Sobi (Anakinra), and Savient (Pegloticase) representing conflicts of interest with pharmaceuticals already in use. Additional relationships were disclosed between researchers and Celgene (Apremilast), AstraZeneca (AZD6140), BioCryst (BCX4208), Merck (Etoricoxib), Novartis (Canakinumab, Lumaricoxib), Ardea Biosciences (Lesurinad), Regeneron (Rilonacept), Glaxo Smith Kline and Nuon Ther

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Gout Supplementary Data Appendix A

    Uploaded by

    acoolz90
    20 views1 page
    Specific relationships were disclosed between researchers and URL Pharma (Colchicine), Takeda (Febuxostat), Amgen/Biovitrum/Sobi (Anakinra), and Savient (Pegloticase) representing conflicts of interest with pharmaceuticals already in use. Additional relationships were disclosed between researchers and Celgene (Apremilast), AstraZeneca (AZD6140), BioCryst (BCX4208), Merck (Etoricoxib), Novartis (Canakinumab, Lumaricoxib), Ardea Biosciences (Lesurinad), Regeneron (Rilonacept), Glaxo Smith Kline and Nuon Ther

    Original Description:

    1234

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Specific relationships were disclosed between researchers and URL Pharma (Colchicine), Takeda (Febuxostat), Amgen/Biovitrum/Sobi (Anakinra), and Savient (Pegloticase) representing conflicts of interest with pharmaceuticals already in use. Additional relationships were disclosed between researchers and Celgene (Apremilast), AstraZeneca (AZD6140), BioCryst (BCX4208), Merck (Etoricoxib), Novartis (Canakinumab, Lumaricoxib), Ardea Biosciences (Lesurinad), Regeneron (Rilonacept), Glaxo Smith Kline and Nuon Ther

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    20 views1 page

    Gout Supplementary Data Appendix A

    Uploaded by

    acoolz90
    Specific relationships were disclosed between researchers and URL Pharma (Colchicine), Takeda (Febuxostat), Amgen/Biovitrum/Sobi (Anakinra), and Savient (Pegloticase) representing conflicts of interest with pharmaceuticals already in use. Additional relationships were disclosed between researchers and Celgene (Apremilast), AstraZeneca (AZD6140), BioCryst (BCX4208), Merck (Etoricoxib), Novartis (Canakinumab, Lumaricoxib), Ardea Biosciences (Lesurinad), Regeneron (Rilonacept), Glaxo Smith Kline and Nuon Ther

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 1

    Supplemental Appendix A:

    Conflict of interest (COI)


    Specific relationships with companies, and respective pharmaceuticals in use representing COI,
    were: URL Pharma (Colchicine); Takeda (Febuxostat); Amgen / Biovitrum / Sobi (Anakinra);
    Savient (Pegloticase). Specific relationships with companies, and respective pharmaceuticals in
    clinical trials representing COI, were: Celgene (Apremilast); AstraZeneca (AZD6140); BioCryst
    (BCX4208); Merck (Etoricoxib); Novartis (Canakinumab, Lumaricoxib); Ardea Biosciences
    (Lesurinad); Regeneron (Rilonacept); Glaxo Smith Kline and Nuon Therapuetics (Tranilast);
    EnzymeRx (Pegadricase).

    You might also like